Brett Sandercock
2013
In 2013, Brett Sandercock earned a total compensation of $2.5M as Chief financial officer at ResMed, a 9% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $448,335 |
---|---|
Salary | $505,266 |
Stock Awards | $1,500,008 |
Other | $52,314 |
Total | $2,505,923 |
Sandercock received $1.5M in stock awards, accounting for 60% of the total pay in 2013.
Sandercock also received $448.3K in non-equity incentive plan, $505.3K in salary and $52.3K in other compensation.
Rankings
In 2013, Brett Sandercock's compensation ranked 3,116th out of 12,286 executives tracked by ExecPay. In other words, Sandercock earned more than 74.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,116 out of 12,286 | 75th |
Division Manufacturing | 1,054 out of 4,612 | 77th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 138 out of 681 | 80th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 80 out of 420 | 81st |
Industry Surgical and Medical Instruments and Apparatus | 43 out of 263 | 84th |
Source: SEC filing on October 1, 2015.
Sandercock's colleagues
We found seven more compensation records of executives who worked with Brett Sandercock at ResMed in 2013.
2013
Peter Farrell
ResMed
Chairman
2013
Michael Farrell
ResMed
Chief Executive Officer
2013
Rob Douglas
ResMed
Chief Operating Officer
2013
Robert Douglas
ResMed
Chief Operating Officer
2013
Jim Hollingshead
ResMed
President - Americas
2013
James Hollingshead
ResMed
President - Americas
2013
David Pendarvis
ResMed